letrozole has been researched along with selenium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abdollahi, M; Ahmadi, A; Baeeri, M; Rezvanfar, MA; Shojaei-Saadi, HA | 1 |
| Abd El-Khalik, SR; Abdelsattar, AM; AbuoHashish, NA; Eltokhy, AK; Farghal, EE; Khattab, HA; Mariah, RA; Mohamed, DA; Rabah, HM; Raslan, MA | 1 |
| Butt, MA; Kiyani, MM; Moghul, NB; Munir, A; Mustafa, M; Shafique, HM; Shamas, U; Tabassum, S | 1 |
3 other study(ies) available for letrozole and selenium
| Article | Year |
|---|---|
Molecular mechanisms of a novel selenium-based complementary medicine which confers protection against hyperandrogenism-induced polycystic ovary.
Topics: Animals; Antioxidants; Biomarkers; Estradiol; Female; Hyperandrogenism; Letrozole; Lipid Peroxidation; Nitriles; Ovary; Oxidative Stress; Plant Extracts; Polycystic Ovary Syndrome; Progesterone; Prostaglandins E; Rats; Rats, Wistar; Selenium; Testosterone; Triazoles; Tumor Necrosis Factor-alpha | 2012 |
Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue.
Topics: Animals; Female; Humans; Insulin Resistance; Letrozole; Lipids; Metformin; Mitochondria; Nanoparticles; Obesity; Oxidation-Reduction; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Selenium; Signal Transduction | 2023 |
Therapeutic Potential of Selenium Nanoparticles on Letrozole-Induced Polycystic Ovarian Syndrome in Female Wistar Rats.
Topics: Animals; Disease Models, Animal; Female; Humans; Interleukin-1; Letrozole; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Selenium | 2023 |